Research reports that 90% of cancers are caused by unhealthy lifestyle habits

Share This Post

Medical experts say that 90% of cancer patients are caused by unhealthy life habits, not DNA plays a leading role. Diet, sunlight, smoking, and disease have a “burn-up” effect on cancer, not caused by bad DNA. Dr. Smith of the British Cancer Institute said that healthy lifestyles such as non-smoking, maintaining a healthy weight, eating healthy food and quitting alcohol cannot ensure that people do not suffer from cancer, but can significantly reduce the probability of cancer.

This suggestion is not surprising. Scientists have divided how many cancer cases are due to people’s living habits, and how many cancer cases are inevitable. The controversy began 1 year ago, when studies reported that most cancer cases occurred due to DNA errors and occurred at random body ages and cell divisions. This means that most cancer patients are due to “bad luck” rather than unhealthy living habits.

At present, the latest research has reached the opposite conclusion. Dr. Yusuf Hannun of Stony Brook University pointed out that although “luck” has a certain effect, people’s unhealthy living habits can seriously affect the incidence of cancer. . These unhealthy lifestyle habits include: diet, drinking, smoking, sunlight, certain viral infections, pollution, and other factors that have not yet been determined.

The research report was published in the journal Nature, and the bad genes inherited from parents are only a cause of a few cancer cases. The results of this study confirm that most cancer cases are caused by environmental factors. If these potential factors can be identified, the incidence of cancer can be controlled.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

After amazing growth of CAR T-Cell therapy what's next
CAR T-Cell therapy

After amazing growth of CAR T-Cell therapy: what’s next?

CAR T-cell therapy has rapidly transformed cancer treatment by reprogramming a patient’s T-cells to attack cancer cells, demonstrating remarkable success in hematologic cancers. Advances in genetic engineering, regulatory support, and investment are driving further expansion. Researchers are now tackling the challenges of applying this therapy to solid tumors, aiming to enhance efficacy and accessibility, marking a new era in personalized cancer therapy and immunotherapy.

Lutetium Lu 177 dotatate is approved by USFDA for pediatric patients 12 years and older with GEP-NETS
Cancer

Lutetium Lu 177 dotatate is approved by USFDA for pediatric patients 12 years and older with GEP-NETS

Lutetium Lu 177 dotatate, a groundbreaking treatment, has recently received approval from the US Food and Drug Administration (FDA) for pediatric patients, marking a significant milestone in pediatric oncology. This approval represents a beacon of hope for children battling neuroendocrine tumors (NETs), a rare but challenging form of cancer that often proves resistant to conventional therapies.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy